✦ LIBER ✦

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

✍ Scribed by Richard M. Zuniga; Roy Torcuator; Rajan Jain; John Anderson; Thomas Doyle; Lonni Schultz; Tom Mikkelsen

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 276 KB
Volume: 99
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-010-0121-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety and patterns of respons

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

✍ R. M. Zuniga; R. Torcuator; R. Jain; J. Anderson; T. Doyle; S. Ellika; L. Schult 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 452 KB

Phase II trial of ritonavir/lopinavir in

Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas

✍ Manmeet S. Ahluwalia; Carol Patton; Glen Stevens; Tanya Tekautz; Lilyana Angelov 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 192 KB

A phase 2 trial of single-agent bevacizu

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas

✍ Jeffrey J. Raizer; Sean Grimm; Marc C. Chamberlain; M. Kelly Nicholas; James P. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 1 views

Noninvasive quantification of18F-FLT hum

Noninvasive quantification of18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma

✍ Heiko Backes; Roland Ullrich; Bernd Neumaier; Lutz Kracht; Klaus Wienhard; Andre 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 237 KB

A phase II study of O6-benzylguanine and

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

✍ Katherine E. Warren; Sri Gururangan; J. Russell Geyer; Roger E. McLendon; Tina Y 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 225 KB

A phase III study of radiation therapy p

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma

✍ Jan C. Buckner; Paula J. Schomberg; William L. McGinnis; Terrence L. Cascino; Be 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views